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Abstract
Collagen is the most abundant protein in the human body and plays an important role in
extracellular matrix organization, support, and elasticity. Of the different types of collagens,
Type I Collagen makes up 90% of the human body’s collagen content. It is a heterotrimer with
two identical polypeptide chains (α1(I) chain) and one polypeptide chain with different amino
acid sequence (α2(I) chain). Naturally, Type I Collagen is also the most studied collagen. Many
Collagen Mimetic Peptides use sequences derived from human Type I Collagen to explore its
folding, structure, and bioactivity. In the bioengineering of collagen mimetic peptides for
biomaterial, there is a great interest in forming peptides with the heterotrimeric and fibril
forming characteristics of Type I Collagen. The previously F877 homotrimer includes a collagen
domain from the α1(I) chain and forms stable triple helices. In hopes of creating a heterotrimeric
triple helix where the collagen domain mimics that of Type I Collagen, we designed new
mimetic peptides based on F877 using collagen sequences from the α2(I) chain. We report two
new constructs α1TRX- and α2TRX- that successfully formed triple helices and can be used in
future designs for homo- or heterotrimers. We show that triple helix folding is dependent on the
triple helical region amino acid sequence, the location of the cross-linking domains as well as the
nucleation domain. We have also completed a preliminary study using the NC2 domain of Type
IX Collagen in an attempt to form heterotrimeric peptides having the desired chain register.

Introduction
Type I Collagen
Collagen, being the most abundant protein in the human body, plays a fundamental role
in extracellular matrix organization, support, and elasticity. Each collagen unit encompasses
three individual polyproline II-like peptide chains that form a triple helix with a one residue
stagger (Brodsky and Ramshaw, 1997; Engel and Bachinger, 2005). The triple helical structure
of the protein is attributed to the distinctive (Gly-X-Y)n amino acid repeats of collagen peptides
(Canty and Kadler, 2005). When folded, the X and Y amino residues of the triplet, commonly
proline and hydroxyproline, become solvent exposed while glycine residues are buried within the
helix (Boudko et al., 2012; Hulmes et al., 1973). Collagen chains are initially synthesized as
procollagen with non-triple helical C- and N-terminal propeptide regions. In particular, the Cpropeptide domain is a key player in chain selection and chain register, as well as serving as a
nucleation domain for triple helix folding (Bulleid, 1996; Doyle and Smith, 1998). The globular
propeptide regions are proteolyzed upon secretion from the cell, allowing individual collagen
triple helices to further self-associate into supramolecular structures (Canty and Kadler, 2005).
This fibrillar form of collagen allows for its crucial load-bearing role in bones, tendons, and
ligaments (Varma et al., 2016). Individual collagen trimers self-associate in a parallel bundle
with a characteristic D-Period of 67 nm (Petruska & Hodge, 1964; Orgel et al., 2006). The
collagen fibril periodicity is visualized with negative staining of TEM (Transmission Electron
Microscopy) methods, revealing the 27 nm (0.4 D) overlap region and 40 nm (0.6 D) gap region
(Piez and Miller, 1974). Such a structure reveals a series of light (overlap) and dark (gap)
striation patterns in TEM images.
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Of the 28 types of collagens known today, Type I Collagen is the most common collagen
found in the human body, comprising almost 90% of the body’s collagen content (Kadler, 2007).
Encoded by the COL1A1 and COL1A2 genes, Type I Collagen is made up of two α1 chains and
one α2 chain that parallelly twist together in triple helical formation (Varma et al., 2016). While
normal Type I Collagen is found in the heterotrimeric form, its homotrimeric (α1(I)) isoform also
occurs naturally. It is noted that while the α1(I) chain forms collagen homotrimers, the
predominant consensus in the field is that α2(I) chains do not self-associate in triple helices.
However, there is little understanding to why α2 homotrimers do not naturally occur given the
extremely high sequence identity and similarity between the two chains (Xu and Kirchner,
2021). A study suggests that charge repulsion between Lys129 of one chain and Lys247 of the
adjacent chain in the α2(I) C-propeptide Chain Recognition Sequence (CRS) forbids the
formation of α2(I) homotrimers (Sharma et al., 2017).
The α1(I) homotrimer is often associated with cellular abnormalities and disease, such as
fibrosis and cancer (Chang et al., 2012). The isoform is also observed in Brittle Bone Disease
(Osteogenesis Imperfecta), where mutations in the COL1A1 or COL1A2 gene results in the
production of homotrimeric Type I Collagen over normal heterotrimeric Type I Collagen (Xu et
al., 2008). Homotrimeric Type I Collagen shows increased resistance to MMP-1 (Matrix
Metalloprotease 1) although the reasoning is still not fully understood (Chang et al., 2012).
Some attribute increased collagenase resistance to the increased stability of the homotrimer as it
lacks the α2 chain (Han et al., 2010). This is because the α2 chain disrupts hydroxylation and
hydrogen binding patterns present in homotrimeric Type I Collagen. (Nerenberg and Collin,
2008) Thus, providing flexibility for local unfolding that precedes proteolysis at the MMP-1
cleavage site (Mekkat et al., 2018).
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Collagen Mimetic Studies
In addition to the role of collagen in diseases and aging, collagen is also a promising
biomaterial scaffold used in many medical treatments. To better study the mechanics and
function of collagen, there has been an increase of collagen mimetic studies over the years. Such
a field encompasses the expression of natural collagen in non-human expression systems as well
as the bioengineering of both native collagen and collagen-like sequences (Brodsky and
Ramshaw, 2017; Xu and Kirchner, 2021). As many of collagen’s dynamic roles are due to its
fibrillar structure, it is of great interest to synthesize fibril forming biomaterial. Likewise, with
the most abundant collagen protein being Type I Collagen also brings about interest in
synthesizing heterotrimeric mimetic peptides. Mimetic peptides allow researchers to explore the
folding mechanism, structure, and stability of collagen and collagen fibrils with the end-goal of
engineering peptides to desired parameters. The use of bioengineered collagens deviates from the
dependence of animal sources which are not applicable for biomedical usage due to
contamination during the purification process.
F877
The Xu lab has been designing collagen mimetics peptides using native collagen
sequences in bacterial expression systems. The laboratory hopes to synthesize heterotrimeric
fibril forming collagen mimetic peptides akin to Type I Collagen. In past research, they have
successfully formed triple helices without hydroxyproline as well as mini-fibrils showcasing 35
nm d-periodicity (Chen et al., 2019; Kaur et al., 2014; Strawn et al., 2018). They show a
minimum of two identical sequence unit (collagen domain) repeats are sufficient to result in
mini-fibrils with periodicity (Chen et al., 2019). The one sequence unit construct, F877, while
unable to form fibrils, forms a stable triple helix with a melting temperature ~38℃ (Xu et al.,
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2018). This is comparable with the melting temperature of native Type I Collagen, which lies
just under that of physiological temperature (Leikina et al., 2002). The structural motifs and
amino acid sequence of F877 are shown below in Figure 1.

Figure 1. F877 Design. The structural motifs of fusion protein F877 from the N-terminus (left) to
C-terminus (right). His-tagged thioredoxin is followed by the thrombin cleavage site. The
collagen domain is a 63 amino acid long sequence from Human Type I Collagen α1 chain
(Residues 877-940). Gly-Ser sequences are introduced into the peptide from restriction enzymes,
and one is placed before the Foldon for flexibility. A cysteine knot is formed in the homotrimer
due to the GPCC (bolded) at the C-terminal end.
The collagen domain is flanked on both sides with (GPP)n repeats for stabilization factors
and a GPCC sequence at the C-terminal forms a cysteine-knot to aid trimerization (Xu et al.,
2008). The fusion peptide includes a thioredoxin domain to increase protein solubility in E. coli
cytoplasm, preventing the formation of inclusion bodies (LaVille et al., 1993; Yasukawa et al.,
1995). This His-tagged thioredoxin calls for further purification steps due to its interactions with
the triple helical domain. The domain is removed by thrombin at the cut site on the c-terminal
side of the His-tagged thioredoxin. However, this purification step runs into a common problem
of the target protein precipitating out as thrombin cleavage requires dialyzing the protein into
neutral pH buffer. Removal of the enzyme and cleaved fragment by High Performance Liquid
Chromatography (HPLC) subsequently also lowers the final yield.
This brings up the notion whether the thioredoxin domain can be removed from the
peptide design. The construct α1TRX- is identical to that of F877 sans the thioredoxin sequence.
As the bulk of protein yield loss occurs during dialysis to neutral pH and thrombin cleavage,
4

bypassing these steps should greatly enhance the purification yield. Using F877 as a positive
control, if the α1TRX- peptide can successfully trimerize into triple helical formation, it can both
greatly shorten the purification process as well as increase overall purification yield.
Foldon
The nucleation domain that is incorporated in the design of F877 is the T4 Fibritin Foldon. The
highly stable β-hairpin homotrimer, having a melting temperature ~60℃ has shown to be a
successful trimerization domain (Frank, 2001; Meier et al., 2004). This is supported by the 2008
study by Xu et al., where homotrimeric F877 forms a stable triple helix. However, in attempt to
synthesize a Type I Collagen mimetic peptide brings up the consideration of chain selection and
chain register. The Foldon domain is then limited by its homotrimeric nature and is not
applicable in designing heterotrimers. Furthermore, its bacteriophage origin becomes a hindrance
in designing collagen mimetic peptides for biomedical purposes. Finding a viable nucleation
domain from human protein sequences greatly broadens the application of synthetic collagen
studies.
Type IX Collagen NC2 Domain
Recent studies on the non-collagenous (NC) domains of different types of collagens bring
promising candidates for trimerization domains. A 2010 study by Boudko et al. found the NC2
domain of the heterotrimeric Collagen IX can be used as a triple helix nucleation domain.
Collagen IX is a fibril-associated collagen with interrupted triple helices (FACIT) and a
heterotrimer of three distinct polypeptide chains (α1, α2 and α3). The NC2 region (~38 amino
acids) itself is also a heterotrimer with three distinct alpha chains (Figure 2).
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NC2α1

GRAPTDQHIKQVCMRVIQEHFAEMAASLKRPDSGAT

NC2α2

GRDATDQHIVDVALKMLQEQLAEVAVSAKREALGAV

NC2α3

GKEASEQRIRELCGGMISEQIAQLAAHLRKPLAPGSI

Figure 2. Sequence of Type IX Collagen NC2 Domain. The amino acid sequence of the noncollagenous domain 2 in Type IX Collagen. The three chains are ~38 amino acids long and come
together to form an alpha-helix coiled coil. The cysteine residues that form disulfide linkage
between the NC2α1(IX) and NC2α3(IX) chains are bolded.

In 2012, Boudko and Bachinger expanded on the earlier experiment to show that the NC2
domain not only functions as a trimerization domain but also selects for chain register. This
greatly opens possibilities in synthetic collagen design—ultimately allowing for a “toolkit” to
assemble trimers in any desired chain selection and register. In theory, both homo- and heterotrimers can be assembled using the NC2 domain. The human origin of the NC2 domain would
also be preferred over the bacteriophage derived Foldon in application to biomaterial. The NC2
domain provides a promising alternative nucleation domain to the Foldon.
Boudko et al. designed peptides with a short collagenous domain (12 residues) using
sequences from Human Type I Collagen α1 and α2 chains. The collagen domain was flanked by
(GPP)4 on the N-terminal side and (GPP)3 on the C-terminal side. The Type IX Collagen NC2
domain (either α1, α2, and α3 chains) was appended at the C-terminal end. A GPCC sequence was
placed at the N-terminus for formation of a cysteine knot to increase trimer stability. We
replaced the short collagen sequence with the 63 amino long sequence used in F877 to synthesize
peptides α1-NC2α1, α1-NC2α2 and α1-NC2α3. The corresponding sequence (residues 877-940)
from Human Type I Collagen α2 chain was used to synthesize α2-NC2α1, α2-NC2α2 and α2NC2α3.
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We hypothesize that the NC2 domain can be used as the nucleation domain to develop
heterotrimeric collagen mimetic peptides; furthermore, because it is more native-like, the
heterotrimeric mini-fibril will expand our scope of collagen research and ability to create new
biomaterials. In order to achieve the heterotrimer peptides at a high expression yield, we further
modified the existing expression construct. We designed the construct α1TRX- using F877 as a
positive control to gauge whether stable triple helices could be formed without thioredoxin. Six
constructs were constructed to using native sequences from the α1 and α2 chains of Type I
Collagen to each of the three alpha chains of the NC2 domain. We learned that the folding and
stability of the designed peptides depends on several factors, including the amino acid residues
of the triple helix domain, the location of the GPCC cross-linking domain, and the nucleation
domain.
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Materials and Methods
Construction of expression plasmids
DNA sequences for the designed peptides (α1TRX-, α2TRX-, α2TRX--N, α1-NC2α1, α1NC2α2, α1-NC2α3, α2-NC2α1, α2-NC2α2 and α2-NC2α3) were codon optimized and subcloned
into a modified pET32a (+) vector using GenScript® Gene Synthesis Services. Constructs were
inserted between the EcoRI and NcoI restriction enzyme sites, with the T7 promoter upstream of
the N-terminus and the T7 terminator downstream of the C-terminus. Each peptide included a
poly-histidine tag at the N-terminus and a nucleation domain at the C-terminus. α1TRX-, α2TRXand α2TRX--N contain the Foldon domain while α1-NC2α1, α1-NC2α2, α1-NC2α3, α2-NC2α1, α2NC2α2 and α2-NC2α3 include the NC2 domain.

Transformation into Competent Cells
The peptides were expressed using Invitrogen One Shot™ BL21(DE3)pLysS Chemically
Competent E. coli cells (Cat. #C606003) optimized for T7-promoter expression systems. Each
construct was separately transformed into competent cells by heatshock technique indicated in
the product manual. Transformation solution was then plated onto LB Agar plates with 100
µg/mL Ampicillin to select for antibiotic resistance. Plasmid DNA purification was performed
on transformed colonies using Promega Wizard® Plus SV Minipreps DNA Purification System
(Cat. #A1330) as instructed by product protocol. DNA concentrations were quantified using
Thermo Scientific™ NanoDrop™ One Microvolume UV-Vis Spectrophotometer. Gene
sequences were then confirmed with Sanger Sequencing services provided by GENEWIZ, Inc
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before proceeding onto expression and purification protocols. The T7 Promoter and T7
Terminator primers were used to sequence the plasmid DNA samples.

Expression and Purification of Target Constructs
Transformed colonies were grown separately in LB Media (10 g Tryptone, 5 g Yeast
Extract, 10 g NaCl, 100 µg/mL Ampicillin per liter) under sterile conditions. 10 mL seeding
cultures were incubated overnight at 37°C, 225 RPM shaking settings before inoculation into
growth media (1 L of 100 µg/mL Ampicillin LB Media) the following day. Cells were grown at
37°C, 225 RPM until optical density at 600 nm reached 0.5 AU. Expression of the targeted
protein was initiated upon the addition of 0.1 mM final concentration of Isopropyl β-D-1thiogalactopyranoside (IPTG). Samples were induced overnight in an incubator (16°C, 225 rpm)
for 18 hours. The NC2 containing constructs, α1-NC2α1, α1-NC2α2, α1-NC2α3 (will now be
mentioned as α1-NC2) and α2-NC2α1, α2-NC2α2, α2-NC2α3 (will now be mentioned as α2-NC2)
were mixed in equal volume ratios after induction and co-purified.
The growth media were centrifugated to collect the cells before resuspension in Lysis
Buffer (50 mM Tris, 300 mM NaCl, pH 7) with added DNAse, lysozyme and
phenylmethylsulfonyl fluoride (PMSF). Cells were then lysed by sonication before another round
of centrifugation to remove cell debris. The supernatant containing the targeted protein was
bound to 2 mL slurry of Thermo Scientific™ HisPur™ Ni-NTA Resin (Cat. #PI88221). The
bound resin was loaded onto a column and washed first with 10 mL 20 mM Imidazole Lysis
Buffer (50 mM Tris, 300 mM NaCl, 1 mM PMSF, pH 7) and subsequently 10 mL 50 mM
Imidazole Lysis Buffer (50 mM Tris, 300 mM NaCl, pH 7). The protein constructs were eluted
with 500 mM Imidazole Lysis Buffer (50 mM Tris, 300 mM NaCl, pH 7) in 1 mL elution
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fractions. Elution fractions were run on a 17% poly-acrylamide gel under reducing conditions.
Sample migration was monitored with GenScript® Broad Multi Color Pre-Stained Protein
Standard (Cat. #M00624). The SDS-PAGE gel was then stained with Coomassie Blue dye for
visualization.
Sample migration was also confirmed using Western Blot for the His-tag epitope. The
proteins were transferred onto Invitrogen’s PDVF (polyvinylidene difluoride) membrane (Cat.
#LC2002) after SDS-PAGE. The membrane was then blocked with 5% milk on a shaker at room
temperature for an hour. Proteins were probed with Invitrogen’s HRP-conjugated 6x-His Tag
Monoclonal Antibody (Cat. #MA1-21315-HRP) in 1:2000 dilution overnight with slight
agitation at 5°C. It was subsequently washed with 1x-TBS-T (8.8 g NaCl, 0.2g KCl, 3g Tris
Base, 500 µL Tween-20 per liter) on a shaker at room temperature. Chemiluminescence was
detected using MilliporeSigma™ Immobilon™ Western Chemiluminescent HRP Substrate
(ECL) (Cat. #WBKLS0050). The Western Blot films was obtained with a Konika SRX-101A XRay Film Developer.
Collected elution fractions were then dialyzed extensively against 5 mM Acetic Acid (pH
4.5) at low temperature (4°C). The protein was kept incubated at 4°C for at least three days after
dialysis to initiate trimerization. Protein concentrations were obtained using a DU800
Spectrophotometer (Beckman Coulter Inc, USA). The mg/mL concentration values were
calculated using absorbance values at 280 nm and Abs 0.1% extinction coefficients provided by
ExPASy ProtParam (Table 1).

Characterization using Circular Dichroism

10

Circular dichroism spectroscopy data was obtained using Chirascan™ V100 (Applied
Photophysics Ltd, UK). Data parameters were manipulated using the Pro-Data Chirascan™
program and experimental temperatures were monitored with the Chirascan™ CS/PSM Turret
T1 temperature probe. Concentrations of samples measured were determined by the Beckman
Coulter DU800 Spectrophotometer. Samples for CD experiments remained in 5 mM Acetic Acid
(pH 4.5). Scans of constructs were taken from 190-260 nm in 1 mm pathlength quartz cuvettes at
5°C. Thermal melt experiments were conducted from 5-60°C increasing one degree per minute.
A scan was taken from 190-260 nm at every one-degree increment, with an equilibration time of
one minute at every temperature point. Sample spectra was corrected using baseline subtraction
of the buffer spectra before being normalized for concentration and converted into mean residual
ellipticity. Normalized circular dichroism data was analyzed with the open-source software
SciDavis, producing a melting curve by monitoring CD values at the negative peak wavelength
per construct. The thermal transition profiles (temperature vs. fraction folded) were fitted to a
Boltzmann’s distribution curve and melting temperature (Tm) was determined where the protein
was 50% folded (Fraction Folded = 0.5)
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Results
Peptide Design
In designing heterotrimeric peptides, our first goal was to synthesize a F877 heterotrimer
where the collagen domain mimics that of Type I Collagen. To maximize purification yield, we
optimized the F877 design by removing the thioredoxin domain. α1TRX- tested whether the
peptides could form triple helices without the domain. While F877 and α1TRX-’s collagenous
domain derives from the α1 chain of Human Type I Collagen, we synthesized two new constructs
replacing the collagen domain with the corresponding sequence from the α2 chain of Type I
Collagen. The two α2-Foldon constructs differ only in the placement of the GPCC sequence, one
on the N-terminal side of the triple helical region and the other on the C-terminal side. From here
on, the constructs will be referred to as α2TRX--N and α2TRX-.
We then designed peptides where the Foldon was replaced by the NC2 domain.
Sequences from the α1(I) and α2(I) chains were separately linked to each of the three alpha chains
of the NC2 domain, yielding six different constructs. Once the homotrimers form stable triple
helices, these constructs can used to form heterotrimers. We aimed to utilize the NC2 domain to
create a trimerization “toolkit”, where we can form homotrimers in any chain composition and
chain register we desired. A single tyrosine was included in the NC2 domain containing peptides
to monitor absorbance at 280 nm.
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A

B

Figure 3. The design of peptides. (A) The structural motifs of the separate constructs starting from
the N-terminal (left) to the C-terminal (right). Trimers of each construct will come together with
a one residue-stagger. Collagen domain from α1(I) are highlighted in blue while collagen domain
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from α2(I) are highlighted in red. The Foldon domain is depicted as a blue circle while the NC2
domain is depicted as a purple box. Gly-Ser (italicized) are introduced by restriction enzymes. A
cysteine knot is formed due to the Gly-Pro-Cys-Cys (bolded) sequence. A Gly-Ser is inserted before
the Foldon for flexibility. (B) The protein sequences of the separate constructs with the respective
collagen domain sequence for each peptide is underlined.
α1TRX- and the α1NC2 constructs contains the 63 amino acid long fragment (residues
877-940) from Human Type I Collagen α1 chain. The α2-NC2 and α2TRX- constructs, on the
other hand, contain the corresponding peptide sequence from Human Type I Collagen α2 chain.
The collagen sequence in each peptides nests between (GPP)n sequence repeats. Peptide motifs
and amino acid sequences are found in Figure 3. Molecular weights and extinction coefficients
for each construct were obtained via the ExPASy ProtParam Tool hosted by the SIB Swiss
Institute of Technology (https://web.expasy.org/protparam/) and are listed in Table 1.

Construct

Molecular Weight

Extinction Coefficient

Extinction Coefficient

(Da)

(M-1 cm-1)

(Abs 0.1% (=1 mg/mL))

α1TRX-

13667.31

8480

0.626

α2TRX-

13636.20

8480

0.622

α2TRX--N

13636.20

8480

0.622

α1-NC2α1

13791.32

1490

0.108

α1-NC2α2

13644.15

1490

0.109

α1-NC2α3

13770.37

1490

0.108

α2-NC2α1

13800.46

1490

0.108

α2-NC2α2

13653.29

1490

0.109

α2-NC2α3

13779.51

1490

0.108

Table 1. Molecular Weights and Extinction Coefficients of Constructs. Listed in the table are the
calculated molecular weights and extinction coefficients per single chain of each peptide construct
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The Expression and Purification of the Peptides
Each construct was purified separately and purified via nickel-affinity resin apart from
the two NC2 containing homotrimers (α1-NC2, α2-NC2) where three individual chains of the
desired homotrimer were mixed and co-purified. Collected elution fractions were run on a 17%
poly-acrylamide gel during SDS-PAGE. The respective monomer, dimer and trimer are
highlighted for each construct. All the constructs appeared as expected on the SDS-PAGE results
as seen in Figure 4. All five constructs all have a molecular weight ~14 kDa and appeared close
to the 15 kDa band as indicated by the molecular weight marker. Under 1x SDS reducing agent
conditions, there were still presence of the dimer and trimer configurations. The dimer (~28 kDa)
appeared just below the 30 kDa marker while the trimer (~42 kDa) appeared just below the 50
kDa. These respective bands are not seen in the untransformed cell (negative control). The
monomer, dimer and trimer bands were also confirmed by the western blot using antibodies
against the His-tag.

15

A

B

α1TRX-

C

α2TRX-

D

α2TRX--N

α1-NC2
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E

α2-NC2

Figure 4. SDS-PAGE of column chromatography elution fractions. Samples were run under
reducing conditions on a 17% poly-acrylamide gel. Collected elution fractions after Ni-NTA
affinity resin chromatography were run alongside an untransformed cell sample (negative
control). The separate constructs shown in the figure are (A) α1TRX- (B) α2TRX- (C) α2TRX-N (D) α1-NC2 and (E) α2-NC2. Monomers, dimers and trimers of each construct are
highlighted in red, blue, orange respectively. Protein migration was confirmed by Western
Blot for His-tag.
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The Folding and the Stability of the Designed Peptides
Protein aggregation was seen during dialysis against 5 mM Acetic Acid (pH 4.5) though
not as aggressive as when dialyzed against Lysis Buffer (pH 7). As switching to neutral pH
buffer resulted in a great loss of protein due to precipitation, experiments on all fusion proteins
were performed at low temperatures and acidic pH to maximize yield. Circular dichroism spectra
were taken at 5°C with samples in 5 mM Acetic Acid (pH 4.5). The CD spectra obtained for
each construct all showcase a negative peak around 198 nm and positive peak around 225 nm
(Figure 5a). The α1-NC2 and α2-NC2 homotrimers show almost identical wavelength scan
profiles, with the lowest magnitude of positive and negative peaks. In comparison, the α1TRX-,
α2TRX- and α2TRX--N have slight positive peaks and a strong negative peak. The negative peak
of α1TRX- show the strongest magnitude, though it is still half of that reported by F877 (Xu et
al., 2008). It is noted that the positive peaks of α1-NC2, α2-NC2 and α2TRX--N do not exceed 0
degrees cm2 dmol-1.
With the CD spectra of the pure NC2 trimer generously provided by Dr. Sergei Boudko’s
lab, the wavelength scan profile of the NC2 containing trimers sans the contribution of the alphahelica; NC2 domain was obtained by equimolar subtraction (Figure 5b). The deconvoluted
wavelength scan reveal what seems to be an inverted alpha-helix CD profile. This shows that the
triple helical region has very little contribution to the wavelength profile of the NC2 containing
constructs. The CD spectra of Foldon containing constructs were not deconvoluted as previous
works of the Xu Lab show minimal contribution of the Foldon domain.
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A

B

Figure 5. Circular Dichroism Spectra. (A) Wavelength scans from 190-260 nm of α1TRX(green), α2TRX- (orange), α2TRX--N (pink), α1-NC2 (turquoise) and α2-NC2 (blue), in 5 mM
Acetic Acid (pH 4) at 5°C. Sample concentrations were 0.31 mg/mL, 1 mg/mL, 1 mg/mL, 0.91
mg/mL and 0.34 mg/mL respectively. CD data was normalized to mean residual ellipticity.
(B) Wavelength scans of α1-NC2 and α2-NC2 without the NC2 domain. Equimolar subtraction
of the pure NC2 CD spectra (provided by Sergei Boudko) to remove the contribution of the
alpha-helical nucleation domain to reveal that of the triple helical region.
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With the CD spectras obtained, the Rpn (ratio of positive (225 nm) to negative (198 nm)
peak) of the separate constructs were determined (Table 2). The Rpn of a pure triple helix is
0.12, providing a value to assess the triple-helical content of the constructs (Feng, 1996).
However, this Rpn value is from natural collagen and collagen mimetic sequences with high
hydroxyproline content. Of the constructs, α1TRX- and α2TRX- show comparable Rpn values
(Rpn ~0.1) suggesting that they formed stable triple helices. The deviation from pure triple
collagen may be due to presence of the His-tagged nucleation domain, indicating lower triple
helical content, as well as the lack of hydroxyproline. In comparison, the α2TRX--N exhibit a
extremely low Rpn value. The two NC2 containing peptides have a Rpn value of 0.87 and agrees
with the deconvoluted CD spectra, the folding of the peptides is not comparable to that of a triple
helix.
Construct
α1TRXα2TRXα2TRX--N
α1-NC2
α2-NC2

Rpn
0.09
0.10
0.02
0.87
0.87

Table 2. Rpn values of constructs. Peak values were determined from the wavelength scans
of each peptide. The Rpn value of NC2 containing domains used the corrected wavelength
scan after equimolar subtraction of the NC2 spectra to see the triple helical contribution of
the peptide.
Temperature melt experiments were conducted on the constructs. As temperature
increased, the negative peak and positive peak of the wavelength scans (190-260 nm) lowered in
magnitude. The end temperature of the thermal melt experiment (60°C) is the reported melting
temperature for the Foldon domain, indicating that the only thermal transition curve in the data is
from the triple helical region. The change in CD signal is due to the transition of the triple helix
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to that of a random coil. Fraction folded (FF) values were calculated using the circular dichroism
data. The thermal transition profile of the constructs were obtained by plotting temperature
against the fraction folded values (Figure 6). From the wavelength scan and Rpn values obtained,
α1TRX- and α2TRX- had formed a triple-helical trimer (Rpn ~ 0.10). These two constructs
exhibit ordered transition profiles (Figure 6a). Contrarily, the thermal transition profiles for the
NC2 containing constructs support the notion that they were not properly folded (Figure 6b). The
experimentally determined melting temperatures (Tm) of α1TRX- and α2TRX- are ~36°C and
~27°C respectively, both lower than the reported Tm of F877 (~38°C).
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A

B

Figure 6. Unfolding Transition Profiles. Temperature melt experiments were performed to assess
the stability of the peptides. Samples were in 5 mM Acetic Acid (pH 4.5). The melting curve was
produced monitoring the CD value at 198 nm (negative peak) from 5-60°C. (A) Thermal transition
profile of α1TRX- (green), α2TRX- (orange) and α2TRX--N (pink) (B) Thermal transition profile of
α1-NC2 (turquoise) and α2-NC2 (blue)
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Discussion
SDS-PAGE results showed that all constructs appeared within the predicted molecular
weight ranges. The bands corresponding to the fusion proteins were not present in the negative
control, confirming successful transformation. Even under reducing conditions (1x SDS),
dimeric and trimeric forms were still present due to the GPCC sequence in the constructs. A
disulfide bond is also formed between the NC2α1 and NC2α3 chains in the six NC2 containing
proteins. Boudko et al. reported in 2010 that the NC2α1 fragment has been shown to
homotrimerize, making it difficult to pinpoint the identity of the dimeric and trimeric forms
present in the α1-NC2 and α2-NC2 elution fractions. This is not an issue for the other constructs
as the Foldon trimer consists of three identical subunits.
The circular dichroism wavelength scan profiles confirmed that α1TRX- and α2TRXformed stable triple helix. We show that it is possible to form stable helices without the
thioredoxin domain. This not only shortens the purification process but also avoids the steps
where we’ve previously encountered the greatest loss in yield. We were also able to form a
homotrimer derived from the α2(I) chain comparable to its α1(I) counterpart previously published
from the Xu Lab. While the wavelength scan profile of the α2 constructs do slightly differ from
α1 constructs, the reasoning is not fully understood. In the future, mutagenesis studies can be
performed to see why α2(I) homotrimers seem to fold less stably than αI(I) homotrimers.
However, the lower Rpn value indicate that α1TRX- and α2TRX- have lower triple helical
content than F877. This may be due to the presence of the His-tag, which was cleaved off with
thioredoxin for the F877 fusion peptide. A 2014 study by Acevedo-Jake reported that the
incorporation of amino acids rare to native collagen disrupts the triple helical formation. Though
the study only reported for the incorporation of one histidine residue at the N-terminus, the
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bundle of 12 negatively charged histidine residues in a trimer may adversely interrupt the triple
helical region of the fusion protein.
The presence of the poly-histidine tag on the α1-NC2 and α2-NC2 constructs may also
disrupt proper folding of the protein. As indicated by the deconvoluted CD spectra, the
nucleation domain successfully folded while the triple helical region did not. It is also noted that
the triple helical region in the six NC2 chains are much longer than those originally designed by
Boudko and colleagues. It may be that the NC2 domain is not a sufficient trimerization domain
for long collagenous domains. The presence of a C-terminal Cys-knot may also be an important
stabilizing factor as it is found in both constructs that successfully folded. In the future, we can
try incorporating this motif into the NC2 constructs.
Both α1TRX- and α2TRX- also show a shallower negative peak at 198 nm in comparison
to F877. The loss of CD signal may indicate lower stability of the triple helical region for reasons
as stated above. It is difficult to tell whether the signal indicates a loosely formed triple helix or
small interruptions of the triple helix fold. However, while the negative peak ellipticity values
are more positive than that of F877, they are comparable to previous reported collagen mimetic
peptides (Col877, Col108) from the Xu lab (Chen et al., 2019; Kaur et al., 2014). The thermal
stability experiments agree with the CD Spectra. Both α1TRX- and α2TRX- show lower melting
temperature compared to F877, Col877 and Col108.
α1TRX- folding into stable triple helix conformation indicates that there is no need for the
thioredoxin region in future fusion peptide designs. However, as the results do indicate a less
stable triple helix, removal of the poly-histidine tag can be explored in future experiments.
Perhaps, removal of the his-tag during the initial column chromatography step with enzyme
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immobilized resin can be an efficient method. In this case, the original dialysis and thrombin
cleavage step can be replaced by two column chromatography steps.
The success of α2TRX- forming a triple helical trimer confirms that the α2(I) fragment can
successfully trimerize despite the notion that α2(I) homotrimers cannot form in vitro. In addition,
expression of the α2TRX- can also be incorporated into heterotrimer studies given that α1TRX- is
its α1(I) counterpart. With the two successfully formed homotrimers, we can build a heterotrimer
that mimics Type I Collagen. Designing constructs with two and more sequence units based on
the two peptides can also allow us to study heterotrimeric fibrils.
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